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Bifid cardiac apex: A rare
morphologic structure
To the Editor:
I read with great interest the case reported
by Sayin and associates1 in the February
2006 issue of the Journal. In this article,
the authors presented an exceedingly un-
common pathologic condition and provided
new insights about the extremes of cardiac
morphogenesis. Although the described case
is interesting, there are some concerns about
the surgical technique. I would like to make
the following comments.
The authors reported that the preopera-
tive oxygen saturation was 92% and, by
surgical intervention, the arterial oxygen
saturation reached 96% postoperatively. As
mentioned by the authors, the right ventric-
ular volume was less than normal and the
arterial desaturation was probably related
to hypoplasia of the right ventricle.
First, the preoperative and postopera-
tive hemodynamic data were lacking, and
the reader could not obtain the necessary
information from the article about the de-
gree of right ventricular and tricuspid valve
hypoplasia. Additionally, the long-term ef-
fects of this accessory chamber on rig h t
ventricular contractile function are not
known. An explanation for why a one and
a half ventricle repair was not tried was
not convincingly given. Finally, the au-
thor s must comment on the possible con-
sequences of partial closure of an atrial
septal defect on an already elevated right
ventricular pressure.
Another issue with the technique is the
persistence of a diverticulum-like chamber
communicating with the left ventricle. The
magnetic resonance imaging indicates that
this chamber is large enough. I wonder
why the authors did not consider this blind
sac as a potential source of postoperative
embolism and arrhythmias.
Because there are scanty data in the
literature, such rare anomalies and their
surgical corrections should be considered
as important opportunities for determining
the most accurate surgical approach. The
description of a rare congenital anomaly is
one aspect of this article, but the applied
technique may lead to some interpretive
errors because of the lack of necessary
data.
Murat Basaran, MD
Goztepe Safak Hospital
Kadikoy Istanbul, Turkey
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Reply to the Editor:
We thank Dr Basaran and appreciate his
kind comments and suggestions regarding
our article.1 First of all, we have to stress
that the purpose of our article was mainly
to describe this rare cardiac morphologic
condition— bifid cardiac apex. Although
the patient was examined by several cardi-
ologists in the preoperative period, none of
them was able to diagnose the pathologic
condition precisely. During the diagnostic
workup, magnetic resonance imaging was
also performed; however, the bifid apex
and the third chamber could not be identi-
fied. As we mentioned in the article, the
preoperative echocardiogram and intraop-
erative data were not consistent. We had no
data about the preoperative right ventricu-
lar volume and tricuspid valve. Therefore,
intraoperatively, we decided to close the
large atrial septal defect partially, without
knowing of the existence of the third cham-
ber. We absolutely agree that the long-term
effects of this accessory chamber on right
ventricular contractile function are not well
known. Also, the intermediate and long-
term results of one and a half ventricle
repair for these kinds of patients are con-
troversial owing to the evidence of pulmo-
nary arteriovenous fistulas on follow-up.
However, we disagree with the underesti-
mation of the blind sac as a potential source
of postoperative embolism and arrhyth-
mias, because the exact pathologic condi-
tion could not be diagnosed preoperatively.
Omer Ali Sayin, MD
Murat Ugurlucan, MD
Emin Tireli, MD
Istanbul University
Istanbul Medical Faculty
Department of Cardiovascular Surgery
Istanbul, Turkey
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Off-pump pulmonary valve placement
To the Editor:
I read with great interest the article by
Berdat and coworkers on off-pump pulmo-
nary valve placement.1 The authors present
the results in 4 patients who underwent
perventricular (transventricular) placement
of a stented Shelhigh valve (Shelhigh, Inc,
Union, NJ). The first clinical application of
this procedure was published recently by
Schreiber and colleagues.2 I would like to
congratulate the authors, who successfully
used the perventricular technique for off-
pump placement of the pulmonary valve.
The perventricular technique was ini-
tially used to close complex muscular ven-
tricular septal defects, and the first report
was published in The Journal of Thoracic
and Cardiovascular Surgery by my col-
leagues and me.3 This technique has also
been used to close perimemebranous ven-
tricular septal defects.4
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The initial experiment with the Shel-
high valve in a self-expandable conduit
was performed in sheep by us and the re-
sults published as a book chapter in Trans-
catheter Valve Repair by Hijazi, Bonhoef-
fer, Feldman, and Ruiz.5 In this animal
experiment, the Shelhigh valve that had
been placed in the self-expanding Cook Z
stent (Cook Inc, Bloomington, Ind) was
placed with the help of a delivery gun into
the right ventricular outflow tract of sheep.
The approach was perventricular and no
cardiopulmonary bypass was used. The
clinical application of this approach fol-
lowed this animal experiment.
I was astonished that none of our animal
work with the Shelhigh valve or the per-
ventricular approach was acknowledged by
Berdat and coworkers in the case report.
Zahid Amin, MD
University of Nebraska/Creighton University
Joint Division of Pediatric Cardiology
Omaha, NE
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Reply to the Editor:
We greatly welcome the valuable com-
ments from our colleague Dr Amin and his
important contribution to the development
of this technique.1 Due to space restrictions
for published articles, we could not go into
details regarding the development and his-
torical background of this new device. We
therefore greatly appreciate that this infor-
mation is still presented to the readership.
We would like to emphasize, however, that
our group was the first to clinically implant
the Shelhigh injectable pulmonary valve,
although Schreiber and colleagues2 were
the first to publish their experience.
Pascal A. Berdat, MD
Thierry P. Carrel, MD
Swiss Cardiovascular Center Bern
Clinic for Cardiovascular Surgery
University Hospital
Bern, Switzerland
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Inflow occlusion in the era of
modern cardiac surgery
To the Editor:
We read with interest the article titled “In-
flow Occlusion Pulmonary Embolectomy
in the Modern Era of Cardiac Surgery” by
Bobadilla and associates.1 The following
points are not clear from the contents of the
article.
First, how was the core temperature
lowered? Was it lowered with a cooling
blanket or just by dropping the temperature
of the operating theater, and how long did
it take for the temperature to drop to 32°C?
Second, for what duration was the in-
flow occluded?
Absence of structural or functional dam-
age to the brain has been noted during
circulatory arrest. Probability of safe circu-
latory arrest according to degree of hypo-
thermia is shown in Table 1.
There are a number of situations wherein
familiarity with inflow occlusion technique
may be of use, such as pulmonary valvot-
omy, aortic valvotomy, and atrial septec-
tomy. Patients who have pulmonary atresia
with intact septum can undergo relief of
right ventricular outflow tract obstruction
with a patch, pulmonary valvotomy, or a
Brock procedure. Other procedures that
have been performed safely by this tech-
nique are tricuspid valvectomy, emergency
perforation of a ventricular septal patch,
obtaining full thickness myocardial biopsy,
and repair of penetrating wounds of the
heart.2
Undoubtedly, this technique represents
a considerable cost savings over the same
procedures performed with cardiopulmo-
nary bypass. In the current economic era of
limited health care budget, any surgical
technique that provides equivalent results
is to be preferred over more expensive al-
ternatives.
Jaswinder Singh, MCh
Rajinder S. Dhaliwal, MCh
Suvakanta Biswal, MS
Naveen Swami, MS
Department of Cardiovascular
& Thoracic Surgery
Postgraduate Institute of
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Reply to the Editor:
We graciously thank the authors of this
letter to the editor for supplying further
TABLE 1. Probability of safe circula-
tory arrest according to hyperthermia
Temperature (°C)
Duration of safe
circulatory arrest (min)
37 3
28 10
18 45-60
Revised from Kouchoukos NT, Blackstone EH,
Doty DB, Hanley FL, Karp RB. Hypothermia, cir-
culatory arrest and cardiopulmonary bypass. In:
Kirklin/Barratt-Boyes Cardiac Surgery, 3rd ed.
Philadelphia: Churchill Livingstone; 2003. p. 80
(Table 2.9A). Reprinted with permission from
Elsevier, Inc.
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